Skiplink Navigation

Main Features

Precision medicine Imaging method provides multi-level view of cell samples

Multiplexed protein map

4i is the first imaging technique which gives a view of biological samples and links multiplexed information in one and the same experiment.


Researchers at the University of Zurich (UZH) have developed a novel method to visualise proteins and generate a comprehensive map of cellular organisation, which could help improve cancer diagnosis and therapy selection.

The method, dubbed 4i for iterative immunofluorescence imaging, is an improvement over standard imaging techniques used in biomedicine because it can generate a systematic survey of the cellular landscape, increasing more than tenfold the number of proteins visible per sample.

According to a UZH statementexternal link, 4i makes it possible to see the distribution of at least 40 proteins in thousands of cells at the same time, and across various levels, from the tissue down to subcellular structures.

“Imagine cell biologists to be journalists. Every experiment is an interview with our cells. With conventional immunofluorescence I can ask three questions, whereas with 4i I can have a discussion on more than 40 topics,” explained Gabriele Gut, a researcher at UZH’s Institute of Molecular Life Sciences and lead author of a paper published this week in the journal Scienceexternal link.

The researchers hope the new method will advance precision medicine, notably in cancer diagnosis.

“We hope that 4i and multiplexed protein maps will help researchers to understand processes better that have been at the centre of biological research for decades,” she added.

The new method can also be used to determine the effects of pharmacological substances on the organisation and physiology of cells.

Neuer Inhalt

Horizontal Line

Like Meh? Let us know.



Your questions become our stories: time to vote

subscription form

Form for signing up for free newsletter.

Sign up for our free newsletters and get the top stories delivered to your inbox.

Click here to see more newsletters